Yatra faces Nasdaq bid-price deficiency; 180-day window to regain compliance
Jul 1, 2026, 9:27 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Deficiency notices create near-term downside risk as investors price in potential delisting risk and costs of a reverse split. History shows small caps failing bid-price tests often sample volatility or decline until regaining compliance, with further downside if the company struggles to meet criteria by the deadline.
AI summary
What happened, with direct paths to the underlying reporting
Yatra Online received a Nasdaq deficiency letter for failing to maintain a $1 closing bid price between May 12 and June 24, 2026. It has 180 days to regain compliance by December 22, 2026, with a possible second extension and the option of a reverse split as a cure. There is no immediate delisting, but expect near-term stock volatility.
Nasdaq notified YTRA for failing to maintain $1 bid price.
Non-compliance period: May 12–June 24, 2026.
180-day window to regain compliance until Dec 22, 2026.
Possible second extension and reverse split if needed.
No immediate delisting anticipated.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event